Trial Outcomes & Findings for HRIPT for Collagen Dressing (NCT NCT06283173)
NCT ID: NCT06283173
Last Updated: 2025-03-12
Results Overview
Inflammatory response graded as 0 through 3: 0=no visible reaction; +=slight, confluent, or patchy erythema; 1=Mild erythema (pink); 2=moderate erythema (definite redness); 3=strong erythema (very intense redness) Definition of letter grades appended to a numerical grade: E = Edema - swelling, spongy feeling when palpated P = Papule - red, solid, pinpoint elevation V = Vesicle - small elevation containing fluid B = Bulla reaction - fluid-filled lesion (blister) S = Spreading - evidence of the reaction beyond the Webril® pad area W = Weeping - result of a vesicular or bulla reaction - serous exudate I = Induration - solid, elevated, hardened, thickened skin Superficial Effects g = Glazing y = Peeling c = Scab, dried film of serous exudate of vesicular or bulla reaction d = Hyperpigmentation (reddish-brown discoloration of test site) h = Hypopigmentation (loss of visible pigmentation at test site) f = Fissuring - grooves in the superficial layers of the skin
COMPLETED
NA
86 participants
48 hours post challenge and 24 hours and 48 hours post-challenge removal
2025-03-12
Participant Flow
All subjects receive the positive control, negative control and test product at the same time. The positive control is only applied at the first visit to ensure the subject responds appropriately to a sensitizer. From then on, both the negative control and test products are applied at the same times at different sites, and both sites are evaluated for a local reaction.
Participant milestones
| Measure |
Test Article (Collagen Wound Dressing) and Negative Control (Distilled Water)
Each subject will be treated with an occlusive patch of the test article (collagen dressing) and the negative control (distilled water) at the same time.
During the induction phase of the study, the test article and negative control will be applied repetitively and continuously on one side of the paraspinal region of the back. Each application will be for approximately 48 hours (weekdays) or 72 hours (weekends) over three weeks for a total of 9 applications. During a subsequent challenge phase at least 10 days after the induction phase, the test article and negative control will be applied for 48 hours. The application sites of the subject will be evaluated at approximately 30 minutes, 24 hours, and 48 hours after removal of the test article and negative control.
|
|---|---|
|
Overall Study
STARTED
|
86
|
|
Overall Study
COMPLETED
|
57
|
|
Overall Study
NOT COMPLETED
|
29
|
Reasons for withdrawal
| Measure |
Test Article (Collagen Wound Dressing) and Negative Control (Distilled Water)
Each subject will be treated with an occlusive patch of the test article (collagen dressing) and the negative control (distilled water) at the same time.
During the induction phase of the study, the test article and negative control will be applied repetitively and continuously on one side of the paraspinal region of the back. Each application will be for approximately 48 hours (weekdays) or 72 hours (weekends) over three weeks for a total of 9 applications. During a subsequent challenge phase at least 10 days after the induction phase, the test article and negative control will be applied for 48 hours. The application sites of the subject will be evaluated at approximately 30 minutes, 24 hours, and 48 hours after removal of the test article and negative control.
|
|---|---|
|
Overall Study
Did not show for first visit
|
10
|
|
Overall Study
Lost to Follow-up
|
12
|
|
Overall Study
Physician Decision
|
7
|
Baseline Characteristics
HRIPT for Collagen Dressing
Baseline characteristics by cohort
| Measure |
Collagen Wound Dressing With Positive and Negative Controls
n=57 Participants
Application of test dressing, 0.5% sodium lauryl sulfate in distilled water, and distilled water on areas of the back or upper arm.
ColActive Plus Collagen Matrix Dressing: Induction phase: Test article applied with Hill Top chamber every 48+ hours over 3 weeks. Rest phase: 10-day rest period with no application.
Challenge phase: Test article applied for 48 hours and evaluated through 48 hours post removal.
The positive control is evaluated at Induction 1 only. The negative control is applied following the same schedule as the test article.
|
|---|---|
|
Age, Continuous
|
48 years
STANDARD_DEVIATION 13 • n=5 Participants
|
|
Sex: Female, Male
Female
|
53 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · African American
|
18 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Asian
|
10 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Caucasian
|
11 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Hispanic
|
14 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Other
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
57 participants
n=5 Participants
|
|
Fitzpatrick Skin Type
I - always burn, does not tan
|
3 Participants
n=5 Participants
|
|
Fitzpatrick Skin Type
II - burn easily, tan slightly
|
14 Participants
n=5 Participants
|
|
Fitzpatrick Skin Type
III - burn moderately, tan progressively
|
10 Participants
n=5 Participants
|
|
Fitzpatrick Skin Type
IV - burn a little, always tan
|
13 Participants
n=5 Participants
|
|
Fitzpatrick Skin Type
V - rarely burn, tan intensely
|
17 Participants
n=5 Participants
|
|
Fitzpatrick Skin Type
VI - never burn, tan very intensely
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 48 hours post challenge and 24 hours and 48 hours post-challenge removalInflammatory response graded as 0 through 3: 0=no visible reaction; +=slight, confluent, or patchy erythema; 1=Mild erythema (pink); 2=moderate erythema (definite redness); 3=strong erythema (very intense redness) Definition of letter grades appended to a numerical grade: E = Edema - swelling, spongy feeling when palpated P = Papule - red, solid, pinpoint elevation V = Vesicle - small elevation containing fluid B = Bulla reaction - fluid-filled lesion (blister) S = Spreading - evidence of the reaction beyond the Webril® pad area W = Weeping - result of a vesicular or bulla reaction - serous exudate I = Induration - solid, elevated, hardened, thickened skin Superficial Effects g = Glazing y = Peeling c = Scab, dried film of serous exudate of vesicular or bulla reaction d = Hyperpigmentation (reddish-brown discoloration of test site) h = Hypopigmentation (loss of visible pigmentation at test site) f = Fissuring - grooves in the superficial layers of the skin
Outcome measures
| Measure |
Test Article (Collagen Wound Dressing)
n=57 Skin sites
Application of test dressing to test site using a 25-mm Hill Top Chamber. One test dressing will be applied directly to the test site (intrascapular region or upper arm) of the subject at each planned exposure.
|
Negative Control (Distilled Water)
n=57 Skin sites
Application of distilled water to test site using a 25-mm Hill Top Chamber. One negative control will be applied directly to the same test site (intrascapular region or upper arm) of the subject throughout the study following the same protocol as the test product.
|
Positive Control (0.5% Sodium Lauryl Sulfate)
Application of 0.5% sodium lauryl sulfate to test site using a 25-mm Hill Top Chamber.
One positive control will be applied directly to a test site (intrascapular region or upper arm) of the subject and will only be applied for Induction 1 (the first 48 hours).
|
|---|---|---|---|
|
Skin Sensitization Reaction Using Berger and Bowman Scale
Mean score at 48 hours post challenge
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Skin Sensitization Reaction Using Berger and Bowman Scale
Mean score at 24 hours post challenge removal
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Skin Sensitization Reaction Using Berger and Bowman Scale
Mean score at 48 hours post-challenge removal
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Every 48-72 hours for 1 (positive control) or 9 (negative control and test) applicationsPopulation: Assessment of the positive control was only planned post-application #1 but was also performed post-application #2.
Assessment of irritation based on the Berger and Bowman scale: Numeric Scores 0 = No evidence of irritation 1. = Minimal erythema, barely perceptible 2. = Moderate erythema, readily visible; or minimal edema; or minimal papular response 3. = Strong erythema; or erythema and papules 4. = Definite edema 5. = Erythema, edema and papules 6. = Vesicular eruption 7. = Strong reaction spreading beyond test site Letter Grades (always upper case) A = Slight glazed appearance B = Marked glazing C = Glazing with peeling and cracking F = Glazing with fissures G = Film of dried serous exudate covering all or a portion of the patch site H = Small petechial erosions and/or scabs Positive control should show a response and negative control should not show a response.
Outcome measures
| Measure |
Test Article (Collagen Wound Dressing)
n=57 Skin sites
Application of test dressing to test site using a 25-mm Hill Top Chamber. One test dressing will be applied directly to the test site (intrascapular region or upper arm) of the subject at each planned exposure.
|
Negative Control (Distilled Water)
n=57 Skin sites
Application of distilled water to test site using a 25-mm Hill Top Chamber. One negative control will be applied directly to the same test site (intrascapular region or upper arm) of the subject throughout the study following the same protocol as the test product.
|
Positive Control (0.5% Sodium Lauryl Sulfate)
n=57 Skin sites
Application of 0.5% sodium lauryl sulfate to test site using a 25-mm Hill Top Chamber.
One positive control will be applied directly to a test site (intrascapular region or upper arm) of the subject and will only be applied for Induction 1 (the first 48 hours).
|
|---|---|---|---|
|
Induction Phase Skin Response
Post-application 2
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
0.5 score on a scale
Interval 0.0 to 2.0
|
|
Induction Phase Skin Response
Post-application 1
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
0.6 score on a scale
Interval 0.0 to 3.0
|
|
Induction Phase Skin Response
Post-application 3
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 4
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 5
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 6
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 7
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 8
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
|
Induction Phase Skin Response
Post-application 9
|
0 score on a scale
Interval 0.0 to 0.0
|
0 score on a scale
Interval 0.0 to 0.0
|
—
|
Adverse Events
Test Article (Collagen Wound Dressing) and Negative Control (Distilled Water)
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Test Article (Collagen Wound Dressing) and Negative Control (Distilled Water)
n=86 participants at risk
Each subject will be treated with an occlusive patch of the test article (collagen dressing) and the negative control (distilled water) at the same time.
During the induction phase of the study, the test article and negative control will be applied repetitively and continuously on one side of the paraspinal region of the back. Each application will be for approximately 48 hours (weekdays) or 72 hours (weekends) over three weeks for a total of 9 applications. During a subsequent challenge phase at least 10 days after the induction phase, the test article and negative control will be applied for 48 hours. The application sites of the subject will be evaluated at approximately 30 minutes, 24 hours, and 48 hours after removal of the test article and negative control.
|
|---|---|
|
General disorders
headache and stomach pain
|
1.2%
1/86 • Number of events 1 • Adverse events were collected for the duration of the study, ~5 weeks.
Adverse event is presented for all subjects by subject since the event was systemic in nature. Each subject received each treatment (test, positive control, and negative control) at a different skin site over the same study period.
|
Additional Information
Director of Regulatory Affairs
Covalon Technologies Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place